In this study, researchers measured the psychological manifestations among patients with BCR-ABL-negative MPNs to determine the effects of anxiety, distress, and depression on symptom burden in this patient population.
Drug abuse may cause an unusual short-term memory syndrome
Researchers sought to evaluate the incidence of cancer-related cognitive impairment in patients with breast cancer in a large prospective, longitudinal, nationwide study. These findings address limitations in previous research.
Moderate physical activity can ease the stress that impairs memory among breast cancer survivors, research indicates.
Mindfulness-based Stress Reduction Reduces Cognitive Deficits in Survivors of Breast and Colorectal CancersDecember 24, 2015
Participation in an MBSR program yields robust and sustained improvement in cancer-related cognitive impairment.
There are benefits for breast and colorectal cancer survivors with mindfulness-based stress reduction, study data indicates.
Findings based on small study of childhood cancer survivors with treatment-related deficits shows benefits of computerized cognitive intervention.
Pretreatment cytokine levels are associated with reduced memory performance among newly diagnosed patients with post-menopausal breast cancer.
Breast cancer and chemobrain: Stress of diagnosis can impair cognitive function before chemotherapy is startedMay 05, 2015
Milder cognitive defects displayed by breast cancer patient even before the initiation of chemotherapy may be attributable to disease-related posttraumatic stress, new study data indicates.
Do cancer treatments alter alleles affecting saliva, thus rendering a Genecept Assay null and void?
For patients undergoing chemotherapy for breast cancer, cognitive complaints after treatment may be associated with changes in brain activity, according to a study.
Adult and young adult cancer survivors face cognitive and sexual late effects from cancer and its treatment, according to data compiled from an online cancer survivorship care planning tool presented at the 2014 ASCO Annual Meeting.
Patients who express pretreatment concern about treatment symptoms such as nausea and memory problems tend to suffer higher symptom burdens during and after anticancer treatment, suggests research.
Cancer does not seem to affect pretreatment cognition in older women with breast cancer, compared to healthy controls; however, cognition may be affected in some subgroups of breast cancer patients.
Elderly with faster cognitive decline were found to have lower risk of cancer mortality, according to research.
Cognitive flexibility, verbal fluency, and processing speed were improved in women whose breast cancer had been treated with chemotherapy and who used exercises to improve executive function, according to a new study.
Pretreatment neurocognitive compromise and fatigue were key contributors to the cognitive effects that are often attributed to chemotherapy.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|